Maybe I'm reading too much into it, but I find this statement telling
they didn't see fit to continue recruiting past 49 patients and the remaining 30 would likely not change the result..
So if the first 49 patients had no benefit then it's unlikely 31 extras would see a benefit
conversely, if the first 49 patients all saw a benefit then it's unlikely 31 extras wouldn't see a benefit
Both scenarios are possible. But it seems more likely to me to be the first scenario for them to stop recruiting. Because if the second scenario was true, surely it would be better to keep recruiting to have that knockout headline: "100% 80/80 patients showed a benefit" right? Why stop at 49?
- Forums
- ASX - By Stock
- DXB
- Ann: CLARITY 2.0 COVID-19 Study Concludes Recruitment
Ann: CLARITY 2.0 COVID-19 Study Concludes Recruitment, page-12
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $209.1M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $579.4K | 1.548M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 7922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 0.370 |
10 | 171185 | 0.365 |
13 | 301942 | 0.360 |
3 | 73000 | 0.355 |
9 | 211495 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 7922 | 2 |
0.380 | 72644 | 5 |
0.390 | 17637 | 3 |
0.395 | 142800 | 4 |
0.400 | 277640 | 8 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online